Promaxo

Promaxo is a medical technology company founded in 2016 and based in Oakland, California. The company focuses on developing patient-centric MRI, robotic, and AI platforms specifically for the prostate cancer market. Promaxo aims to enhance healthcare quality, speed, and cost-efficiency through its innovative medical imaging and minimally invasive robotic solutions. The flagship product is a single-sided MRI system that is compact, adaptable, and FDA-cleared for in-office use. This system integrates AI-based imaging to assist medical practices and hospitals in accurately guiding prostate interventions, improving diagnostic precision and treatment outcomes. Additionally, Promaxo develops robotic technologies that complement its imaging platform, enabling precise, minimally invasive procedures. Promaxo serves a customer base that includes urologists, radiation oncologists, and hospitals specializing in prostate cancer care. The company is actively expanding its market reach and exploring new applications beyond prostate cancer.

• Employees 58
• Founded 2016
• Annual Revenue $10000000
• Total Funding $61209728